Amnis Corporation

What Amnis Corporation does

Amnis Corporation, founded in 1999 and headquartered in Seattle, Washington, is a flow cytometry instrumentation company now operating as a subsidiary brand of Cytek Biosciences. The company's core technical contribution is imaging flow cytometry — combining flow cytometry with fluorescence microscopy to enable simultaneous morphological and fluorescence analysis of individual cells via the Cytek® Amnis® ImageStream®X and the legacy FlowSight® and CellStream® systems. At the platform level, the combined Cytek/Amnis architecture is built on Full Spectrum Profiling (FSP®) technology, which detects entire fluorochrome emission spectra rather than relying on conventional peak-emission bandpass filters, enabling multicolor panels of 40+ colors from a single tube without optical-filter swaps.

The product portfolio spans high-throughput full-spectrum systems (Cytek Aurora™ series including Aurora, Aurora Evo, and Aurora CS), mid-range systems (Northern Lights™, NL-CLC, Orion™), compact cell analyzers (Cytek® Muse® Micro, Cytek® Guava® Muse®, Cytek® Guava® easyCyte™), the next-generation Cytek Borealis™, and the legacy Amnis imaging-flow product line. These instruments are sold alongside a consumables and software ecosystem: cFluor® reagents, FSP® Reagent Kits, Tonbo® reagents, SpectroFlo® software, the Cytek® Cloud platform, and the Spectrum Viewer panel-design tool, plus service plans (Preventative Maintenance, Value Service, Premium Service), IQ/OQ, training, validation, and Design-In applications support.

The business model is a hybrid of capital-equipment sales and recurring consumables revenue. Instruments are sold via quote-based, multi-year enterprise contracts through direct sales and a global distributor network, while reagents and consumables are also offered through an online e-commerce storefront with 20-40% volume-based discounts (the 'Power Your Experiments For Less' program) and USD/EUR pricing. Customers are life-science researchers in academic institutions, pharmaceutical companies, and biotech firms working in immuno-oncology, drug discovery, genomics, immunoprofiling, infectious disease, and inflammatory disease. The company operates dedicated regional commercial footprints in the USA, Japan, China, and an International market.

Name

Amnis Corporation

Legal name

Amnis Corporation

Website

https://amnis.com

Company type

Private

Founded year

1999

Operating status

Acquired

Headcount range

11–50 employees

Short description

Amnis Corporation, a Seattle-based flow cytometry firm founded in 1999 and now a subsidiary of Cytek Biosciences, manufactures imaging flow cytometers (Cytek® Amnis® ImageStream®X and legacy FlowSight®/CellStream®) that combine fluorescence microscopy with flow cytometry for life-science researchers in immuno-oncology, drug discovery, and genomics.

Ownership category

akta.pro rank

Product category

Flow Cytometry Instruments

NAICS

Analytical Laboratory Instrument Manufacturing (334516)

SIC

Laboratory Analytical Instruments (3826)

akta.pro primary industry

Microscopy, Imaging & Flow Cytometry Instruments (HLAGAIAE)

Keywords

• Imaging flow cytometry
• Flow cytometry instruments
• Cell analysis systems
• Fluorescence microscopy instruments
• Research laboratory equipment

Headquarters

HQ city

Seattle

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Technology or R&D, Supply Chain, Personnel, Marketing or Sales

Pricing tiers

Distribution channels3 records

Marketing channels7 records

Core offering

Amnis Corporation manufactures and supplies imaging flow cytometry instruments, primarily the Cytek® Amnis® ImageStream®X system, which combines high-throughput flow cytometry with fluorescence microscopy to deliver simultaneous morphological and fluorescence analysis of individual cells. The offering is supported by proprietary Full Spectrum Profiling (FSP®) technology, cFluor® reagents, SpectroFlo® software, and related service and training offerings. Amnis-branded products are now sold as a Cytek® Amnis® product line under parent company Cytek Biosciences.

Product overview

Amnis Corporation, acquired by Cytek Biosciences, offers a comprehensive portfolio of cell analysis solutions centered on full spectrum flow cytometry technology. The product portfolio includes multiple instrument tiers: the Cytek Aurora™ series (including Aurora Evo and Aurora CS variants) as the core high-performance full spectrum flow cytometry systems capable of 40+ color analysis; Cytek Northern Lights™ and Cytek® NL-CLC for mid-range applications; Cytek Borealis™ as the next-generation system; the Cytek® Muse® and Cytek® Guava® sub-brands for compact and accessible cell analysis; Cytek Orion™ for additional workflow solutions; and Cytek® Amnis® ImageStream®X for image-based flow cytometry. These instruments are complemented by cFluor® Reagents optimized for spectral cytometry, FSP® Reagent Kits, SpectroFlo® and Cytek® Cloud software platforms for data acquisition and analysis, and comprehensive service offerings including preventative maintenance, training, validation, and Design-In applications support. The architecture represents a platform-plus-modules approach where the FSP (Full Spectrum Platform) technology serves as the unifying foundation across instruments, reagents, and software.

Differentiator

Problem solved

Functional benefit

Brands

• Cytek® Amnis® ImageStream®X: Image flow cytometry system - legacy product line acquired by Cytek Biosciences
• Cytek® Amnis® FlowSight®
• Cytek® Amnis® CellStream®

Products and services

• Cytek® Amnis® ImageStream®X An imaging flow cytometer that combines fluorescence microscopy with flow cytometry, enabling high-throughput morphological analysis of individual cells along with fluorescence readouts. Designed for life science researchers in immuno-oncology, immunology, drug discovery, and genomics applications.
• Cytek® Amnis® FlowSight® A legacy image-based flow cytometer system from the Amnis product line, discontinued but still supported for installed customers.
• Cytek® Amnis® CellStream® A legacy flow cytometry system from the Amnis product line, discontinued but still supported for installed customers.
• Service Plans Service contracts offering preventative maintenance, value service, and premium service tiers for Amnis-branded flow cytometry instrument support.
• Training Technical training services for operating Amnis/Cytek imaging flow cytometry instruments and developing optimized experimental workflows.
• Validation Validation services to ensure Amnis/Cytek instrument performance meets specifications for regulated research environments.
• Design-In Expert applications support service for panel design and experimental workflow optimization on Amnis/Cytek imaging flow cytometry instruments.

Quantifiable outcome

• Panels of 40+ colors without sacrificing data resolution
• +2 more outcomes

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature8 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• Standard BioTools (formerly Fluidigm): Mass cytometry and imaging mass cytometry provider (Hyperion, CyTOF platforms) serving immuno-oncology and immunology researchers. Comparable as a high-parameter cell analysis specialist with novel imaging-based detection approaches.
• Sony Biotechnology: Manufacturer of flow cytometry and cell sorting instruments (MA900, SH800, ID7000) focused on spectral and high-parameter cell analysis. Directly comparable as a competing flow cytometry specialist with adjacent spectral and imaging capabilities.

Broad incumbents

• Cytek Biosciences: Parent company of Amnis and the leading provider of full-spectrum flow cytometry systems including the Aurora, Northern Lights, and Borealis platforms. Directly comparable as the acquirer that now sells Amnis imaging flow cytometry products within a wider spectral flow portfolio.
• BD Biosciences: A division of Becton Dickinson and a global leader in flow cytometry instruments (BD FACSort, BD Symphony), reagents, and cell sorting. Directly comparable as a dominant incumbent serving life science researchers in immuno-oncology and drug discovery with broad cell analysis platforms.
• Beckman Coulter Life Sciences: Major flow cytometry and cell analysis instrument provider (CytoFLEX, Navios, Gallios) serving pharma, biotech, and academic research labs. Comparable as a broad incumbent offering overlapping cell analysis instrumentation.
• Miltenyi Biotec: Provider of cell analysis instruments (MACSQuant), reagents, and cell separation products for immunology and cell therapy research. Comparable as a vertically integrated flow cytometry and cell analysis peer serving overlapping customer segments.
• Thermo Fisher Scientific: Provides flow cytometry products (Attune, Invitrogen reagents, Bigfoot cell sorter) as part of its life sciences instrumentation portfolio. Comparable as a broad incumbent with overlapping cell analysis instruments, reagents, and consumables.
• Agilent Technologies (Cell Analysis): Provides cell analysis instrumentation including flow cytometry acquired through the Resolution Biosciences and other life science businesses. Comparable as a broad analytical instrument supplier with overlapping cell analysis offerings.

Others

• Cytobank (Beckman Coulter): Cloud-based flow cytometry data analysis platform now part of Beckman Coulter. Comparable as an adjacent ecosystem participant enabling flow cytometry data management and analysis, similar to Cytek's SpectroFlo and Cytek Cloud.

Emerging players

• NanoCellect Biomedical: Developer of microfluidic flow cytometry and cell sorting platforms (WOLF Cell Sorter) targeting genomics and cell therapy applications. Comparable as an emerging flow cytometry specialist addressing cell analysis workflows.

Market position

Strengths3 records

Weaknesses3 records

Competitive moat4 records

Key risks4 records

Key highlights4 records

Customer concentration

• Xtwitter.com/CytekBio
• YouTubeyoutube.com/channel/UC-meeF2kA-6tVCCrYOiD1Mg
• Facebookfacebook.com/cytekbio
• LinkedInlinkedin.com/company/amnis-corporation

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds4 records

Investors11 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Amnis Corporation